DX-8951f in Treating Patients With Metastatic Stomach Cancer
NCT00017212
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
INDUSTRY
Sponsor class
Conditions
Esophageal Cancer
Gastric Cancer
Interventions
DRUG:
exatecan mesylate
Sponsor
Daiichi Sankyo